Clinical Trials in Atlanta

Showing 17681-17700 of 19,805 trials

Immunotoxin Therapy in Treating Patients With Malignant Glioma

NCT00006268

RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. This may be an effective treatment for malignant glioma. PURPOSE: Phase I/II trial to study the effectiveness of immunotoxin therapy in treating patients who have malignant glioma.

Brain and Central Nervous System Tumors

New Approaches to Brain Tumor Therapy ConsortiumStarted Oct 2000

Birmingham, Alabama, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

NCT00045539

RATIONALE: Drugs used in chemotherapy, such as methotrexate and thiotepa, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining methotrexate with thiotepa in treating patients who have newly-diagnosed primary CNS lymphoma.

Lymphoma

New Approaches to Brain Tumor Therapy ConsortiumStarted Oct 2002

Birmingham, Alabama, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +6 more locations

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Find Trials by Condition in Atlanta

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Suramin in Treating Patients With Recurrent Primary Brain Tumors

Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation